- ICH GCP
- 미국 임상 시험 레지스트리
- Search trials
설사를 동반한 과민성 대장 증후군에 대한 임상 시험
총 1850 건
-
Revogenex, Inc.정지된
-
Novartis완전한
-
Money, Mary E., M.D.빼는
-
University of MichiganNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)완전한
-
Hospital de Clinicas José de San MartínSILVATEAM완전한
-
Furiex Pharmaceuticals, Inc완전한
-
Furiex Pharmaceuticals, Inc완전한
-
Furiex Pharmaceuticals, Inc완전한
-
University of Vienna완전한
-
National University of MalaysiaCotra Enterprises Sdn. Bhd.모병
-
Shahid Beheshti University of Medical Sciences완전한
-
GlaxoSmithKline완전한
-
Bausch Health Americas, Inc.완전한
-
Astellas Pharma Inc완전한변비가 있는 과민성 대장 증후군(IBS-C) | 만성 변비(CC)(기질 질환으로 인한 변비 제외)일본
-
Mayo ClinicNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)완전한
-
Uppsala UniversityThe Swedish Society of Medicine; Medtronics, Inc.; Bengt Ihre Foundation완전한
-
Drink PoppiCitruslabs완전한
-
University of Helsinki모집하지 않고 적극적으로
-
Karolinska InstitutetPraktikertjänst AB (Ltd)완전한IBS - 과민성 대장 증후군스웨덴
-
Baylor College of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)완전한
-
Region Skane완전한
-
Baylor College of MedicineNational Institute of Nursing Research (NINR); University of Washington완전한
-
Istituto Clinico Humanitas모병
-
University of California, Los Angeles모병
-
Gazi UniversityTC Erciyes University; Enbiosis Biotechnology완전한
-
Xiyuan Hospital of China Academy of Chinese Medical...알려지지 않은
-
Glycom, Inc.University of North Carolina완전한
-
Wageningen University and ResearchNexira; Roquette Frères; Bioiberica; Ingredion Incorporated; Winclove Probiotics B.V.; Wecare; Ingredia... 그리고 다른 협력자들완전한
-
Nanjing First Hospital, Nanjing Medical University아직 모집하지 않음